The UK Life Sciences sector is brimming with potential. To maximise this, bold innovation needs capital, confidence, and the right conditions to grow.
We are here to unlock the most promising opportunities and connect them to the right investors. As a new venture fund, we are powered by a unique commitment: to reinvest Medicines Discovery Catapult’s earnings back into the sector we serve.
We utilise our national perspective to seek early-stage ventures that others might miss. Our investments are guided by market demand signals, grounded in real-world need, and backed up by industry-leading due diligence.
Once we identify ventures with the highest potential, we leverage Medicines Discovery Catapult’s deep scientific and industrial capability to assess the idea and enhance its path to translation. Only when ventures are ‘fit-to-fund’ do we bring in our investor partners. Sometimes that means capital. Sometimes it means counsel. But for every innovator we work with, it means building a stronger case for commercial success.
Partnering with us means backing breakthroughs so we can all enjoy outstanding returns for founders, funders, and the nation’s future health.
We are a new venture fund born from a commitment to reinvest Medicines Discovery Catapult’s earnings into building a stronger UK Life Sciences sector.
Creating better health outcomes and outstanding returns for investors, innovators, and patients alike – depends on backing the right breakthroughs.
We identify high-potential ideas by tracking national demand signals.
